0
0
Home » Medical Devices » Ophthalmic Devices

Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Vitreo retinal surgical devices are used for surgical procedures that treat eye problems involving the retina, macula, and vitreous fluid. GlobalData's Medical Devices sector report, “Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Vitreo Retinal Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Vitreo Retinal Surgery Devices report provides key information and data related to:

Extensive coverage of the Vitreo Retinal Surgery Devices under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Vitreo Retinal Surgery Devices pipeline products.

Review of Recent Developments in the segment / industry

The Vitreo Retinal Surgery Devices report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Vitreo Retinal Surgery Devices under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Vitreo Retinal Surgery Devices under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Vitreo Retinal Surgery Devices and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Vitreo Retinal Surgery Devices under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Players

ABVC BioPharma Inc

AcuSurgical

Alcon Inc

Bausch & Lomb Inc

Beaver-Visitec International Inc

Boston College

Cambridge Polymer Group Inc

Carnegie Mellon University

Duke University

Dutch Ophthalmic Research Center International BV

Johns Hopkins University

King's College London

Medisse BV (Inactive)

RetinaSense

Synergetics USA, Inc. (Inactive)

The Chinese University of Hong Kong

University of Kansas

University of Minnesota

Table of Contents

1 Table of Contents

2 Introduction 8

2.1 Vitreo Retinal Surgery Devices Overview 8

3 Products under Development 9

3.1 Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 9

3.2 Vitreo Retinal Surgery Devices – Pipeline Products by Territory 10

3.3 Vitreo Retinal Surgery Devices – Pipeline Products by Regulatory Path 11

3.4 Vitreo Retinal Surgery Devices – Pipeline Products by Estimated Approval Date 12

3.5 Vitreo Retinal Surgery Devices – Ongoing Clinical Trials 13

4 Vitreo Retinal Surgery Devices – Pipeline Products under Development by Companies 14

4.1 Vitreo Retinal Surgery Devices Companies – Pipeline Products by Stage of Development 14

4.2 Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 15

5 Vitreo Retinal Surgery Devices Companies and Product Overview 16

5.1 ABVC BioPharma Inc Company Overview 16

5.1.1 ABVC BioPharma Inc Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 AcuSurgical Company Overview 20

5.2.1 AcuSurgical Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 Alcon Inc Company Overview 21

5.3.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 Bausch & Lomb Inc Company Overview 25

5.4.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.5 Beaver-Visitec International Inc Company Overview 35

5.5.1 Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview 35

5.6 Boston College Company Overview 36

5.6.1 Boston College Pipeline Products & Ongoing Clinical Trials Overview 36

5.7 Cambridge Polymer Group Inc Company Overview 37

5.7.1 Cambridge Polymer Group Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.8 Carnegie Mellon University Company Overview 38

5.8.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 38

5.9 Duke University Company Overview 39

5.9.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 39

5.10 Dutch Ophthalmic Research Center International BV Company Overview 40

5.10.1 Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview 40

5.11 Johns Hopkins University Company Overview 43

5.11.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 43

5.12 King's College London Company Overview 44

5.12.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview 44

5.13 Medisse BV (Inactive) Company Overview 45

5.13.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 45

5.14 RetinaSense Company Overview 46

5.14.1 RetinaSense Pipeline Products & Ongoing Clinical Trials Overview 46

5.15 Synergetics USA, Inc. (Inactive) Company Overview 47

5.15.1 Synergetics USA, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 47

5.16 The Chinese University of Hong Kong Company Overview 48

5.16.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 48

5.17 University of Kansas Company Overview 49

5.17.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 49

5.18 University of Minnesota Company Overview 50

5.18.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 50

6 Vitreo Retinal Surgery Devices- Recent Developments 51

6.1 Feb 03, 2022: Bausch Health Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23 51

6.2 Feb 03, 2022: Bausch Health Companies Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23 51

6.3 Jan 11, 2022: Bausch Health Will Provide Business And Strategic Update At The 40th Annual JP Morgan Healthcare Conference 51

6.4 Jan 05, 2022: Bausch health to participate at the 40th annual J.P. Morgan healthcare conference 51

6.5 Dec 14, 2021: Pixium Vision to attend 11th Annual LifeSci Partners Corporate Access Event 52

6.6 Dec 08, 2021: Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial following first patient implantation in the UK 52

6.7 Nov 02, 2021: Bausch Health Companies Announces Third-Quarter 2021 Results 53

6.8 Sep 29, 2021: Bausch Health Releases Annual Environmental, Social and Governance Report 53

6.9 Aug 03, 2021: Bausch Health Announces Second-Quarter 2021 Results 54

6.10 Jul 27, 2021: Pixium Vision announces its financial results for H1 2021 and provides a business update 56

6.11 Jul 06, 2021: Bausch Health Companies Will Release Second-Quarter 2021 Financial Results On August 3 56

6.12 May 05, 2021: Nanoscope presents novel gene delivery and electrophysiology platforms at ARVO 57

6.13 May 04, 2021: Bausch Health Companies Announces First-Quarter 2021 Results 57

6.14 Apr 28, 2021: Bausch Health Announces 2021 Annual Meeting of Shareholder Results 58

7 Appendix 60

7.1 Methodology 60

7.2 About GlobalData 63

7.3 Contact Us 63

7.4 Disclaimer 63

List of Tables

Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 9

Vitreo Retinal Surgery Devices – Pipeline Products by Territory 10

Vitreo Retinal Surgery Devices – Pipeline Products by Regulatory Path 11

Vitreo Retinal Surgery Devices – Pipeline Products by Estimated Approval Date 12

Vitreo Retinal Surgery Devices – Ongoing Clinical Trials 13

Vitreo Retinal Surgery Devices Companies – Pipeline Products by Stage of Development 14

Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 15

ABVC BioPharma Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Vitargus – Product Status 16

Vitargus – Product Description 16

ABVC BioPharma Inc – Ongoing Clinical Trials Overview 18

Vitargus – A Prospective Multi-site Randomized Controlled Clinical Investigation of the Safety and Effectiveness of the ABV1701 Ocular Endotamponade (OE) 19

AcuSurgical Pipeline Products & Ongoing Clinical Trials Overview 20

Robotic Surgical Assistant – Product Status 20

Robotic Surgical Assistant – Product Description 20

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Finesse Reflex Handle – Product Status 21

Finesse Reflex Handle – Product Description 21

New CONSTELLATION Vitreoretinal System – Product Status 22

New CONSTELLATION Vitreoretinal System – Product Description 22

Next Generation Vitreo-retinal System – Product Status 22

Next Generation Vitreo-retinal System – Product Description 22

Next-Generation Phaco Vit-Ret Console – Product Status 23

Next-Generation Phaco Vit-Ret Console – Product Description 23

Ngenuity 2.0 – Product Status 23

Ngenuity 2.0 – Product Description 23

Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 25

BLS – 005: Retina – Product Status 25

BLS – 005: Retina – Product Description 25

BLS – 009: Retina – Product Status 26

BLS – 009: Retina – Product Description 26

BLS – 012: Retina – Product Status 26

BLS – 012: Retina – Product Description 26

BLS – 013: Retina – Product Status 27

BLS – 013: Retina – Product Description 27

BLS – 018: Retina – Product Status 27

BLS – 018: Retina – Product Description 27

BLS – 019: Retina – Product Status 28

BLS – 019: Retina – Product Description 28

BLS – 020: Retina – Product Status 28

BLS – 020: Retina – Product Description 28

BLS – 021: Retina – Product Status 29

BLS – 021: Retina – Product Description 29

BLS – 022: Retina – Product Status 29

BLS – 022: Retina – Product Description 29

BLS – 023: Retina – Product Status 30

BLS – 023: Retina – Product Description 30

BLS – 024: Retina – Product Status 30

BLS – 024: Retina – Product Description 30

BLS – 025: Retina – Product Status 31

BLS – 025: Retina – Product Description 31

BLS – 026: Retina – Product Status 31

BLS – 026: Retina – Product Description 31

BLS – 027: Retina – Product Status 32

BLS – 027: Retina – Product Description 32

BLS – 028: Retina – Product Status 32

BLS – 028: Retina – Product Description 32

BLS – 029: Retina – Product Status 33

BLS – 029: Retina – Product Description 33

BLS – 030: Retina – Product Status 33

BLS – 030: Retina – Product Description 33

BLS – 031: Retina – Product Status 34

BLS – 031: Retina – Product Description 34

Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Velvet – Product Status 35

Velvet – Product Description 35

Boston College Pipeline Products & Ongoing Clinical Trials Overview 36

Visual Prosthetic Device – Product Status 36

Visual Prosthetic Device – Product Description 36

Cambridge Polymer Group Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Retinal Tamponade – Product Status 37

Retinal Tamponade – Product Description 37

Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 38

Micron – Product Status 38

Micron – Product Description 38

Duke University Pipeline Products & Ongoing Clinical Trials Overview 39

Secure Locking Cannula – Product Status 39

Secure Locking Cannula – Product Description 39

Dutch Ophthalmic Research Center International BV Pipeline Products & Ongoing Clinical Trials Overview 40

Eva Nexus – Product Status 40

Eva Nexus – Product Description 40

Dutch Ophthalmic Research Center International BV – Ongoing Clinical Trials Overview 41

Eva Nexus – EVA Nexus Field Observation Study 42

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 43

Microsurgical Tool – Product Status 43

Microsurgical Tool – Product Description 43

King's College London Pipeline Products & Ongoing Clinical Trials Overview 44

DOF – Haptic Device – Product Status 44

DOF – Haptic Device – Product Description 44

Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 45

PTMC Scleral Buckle – Product Status 45

PTMC Scleral Buckle – Product Description 45

RetinaSense Pipeline Products & Ongoing Clinical Trials Overview 46

RetinaSense Device – Product Status 46

RetinaSense Device – Product Description 46

Synergetics USA, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 47

Intraoperative Device – Product Status 47

Intraoperative Device – Product Description 47

The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 48

Scleral Buckles – Product Status 48

Scleral Buckles – Product Description 48

University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 49

Subretinal Fluid Drainage Cannula – Product Status 49

Subretinal Fluid Drainage Cannula – Product Description 49

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 50

Scleral Depressor System – Product Status 50

Scleral Depressor System – Product Description 50

Glossary 62

List of Figures

Vitreo Retinal Surgery Devices – Pipeline Products by Stage of Development 9

Vitreo Retinal Surgery Devices – Pipeline Products by Territory 10

Vitreo Retinal Surgery Devices – Pipeline Products by Regulatory Path 11

Vitreo Retinal Surgery Devices – Pipeline Products by Estimated Approval Date 12

Vitreo Retinal Surgery Devices – Ongoing Clinical Trials 13

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports